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1.1 General	  notes	  
Dry	  dichloromethane	  (DCM)	  was	  obtained	  by	  passing	  commercially	  available	  DCM	  through	  a	  column	  
containing	  activated	  alumina	  and	  under	  argon	  atmosphere.	  Column	  chromatography	  was	  performed	  
on	  Merck	   silica	   gel	   Si-­‐60	   (40-­‐63	   µm).	   Routine	   chemicals	   were	   supplied	   by	   Sigma-­‐Aldrich	   Co.,	   Alfa	  
Aesar,	  Acros	  organics.	  They	  were	  used	  without	  further	  purification.	  
Unless	  stated	  otherwise,	  all	  spectra	  were	  acquired	  at	  297	  K	  on	  a	  Bruker	  AVANCE	  300	  (300	  MHz	  &	  75	  
MHz	  for	  1H	  and	  13C,	  respectively)	  or	  on	  a	  Bruker	  AVANCE	  500	  (500	  MHz	  &	  125	  MHz	  for	  1H	  and	  13C,	  
respectively)	  as	   indicated.	  Chemical	  shifts	  δ	  are	  reported	   in	  ppm	  with	  reference	  to	  residual	  solvent	  
signals;	   peaks	   are	   annotated	   as	   follows:	   s=singlet,	   d=doublet,	   t=triplet,	   m=multiplet,	   br=broad;	  
coupling	  constants	  J	  are	  given	  in	  Hertz	  (Hz)	  and	  refer	  to	  (H,H)	  coupling.	  Unit	  masses	  were	  measured	  
by	  direct	  injection	  into	  the	  mass	  analyzer	  of	  an	  AGILENT	  1100	  SL	  LC-­‐MS	  system	  running	  in	  ESI	  mode.	  
HRMS	  data	  was	  obtained	   from	  the	  Centre	  Commun	  de	  Spectrométrie	  de	  Masse,	  Université	  Claude	  
Bernard,	  Lyon,	  France.	  




A	  suspension	  of	  compound	  3	  (1.0g,	  2.31mmol,	  1,0eq.),	  compound	  4	  (285mg,	  2.31mmol,	  1.0eq.)	  and	  
silver	  oxide	  (541mg,	  2.31mmol,	  1.0eq.)	  in	  acetonitrile	  (40mL)	  was	  stirred	  at	  RT	  for	  4h.	  The	  progress	  of	  
the	  reaction	  can	  be	  monitored	  by	  TLC	  (cyclohexane	  :	  ethyl	  acetate	  /	  6:4	  /	  v:v).	  After	  the	  completion	  
of	   the	   reaction,	   the	   volatiles	  were	   removed	   under	   reduced	   pressure.	   The	   crude	  mixture	  was	   then	  
passed	  through	  a	  small	  plug	  of	  silicagel	  using	  cyclohexane	   :	  ethyl	  acetate	  /	  1:1	  /	  v:v	  as	  eluent.	  The	  
solvent	  was	  evaporated	  to	  give	  5	  as	  colorless	  oil	  which	  crystallizes	  upon	  standing	  (1.016g,	  2.25mmol,	  
yield:	  97%).	  
NMR:	  1H-­‐NMR	  (300	  MHz,	  CDCl3):	  δ=	  9.86	  (s,	  1H),	  7.80	  (d,	  J	  =	  8.7	  Hz,	  2H),	  7.07	  (d,	  J	  =	  8.7	  Hz,	  2H),	  5.53	  
–	  5.39	  (m,	  2H),	  5.17	  (d,	  J	  =	  7.9	  Hz,	  1H),	  5.10	  (dd,	  J	  =	  10.4,	  3.4	  Hz,	  1H),	  4.23	  –	  4.08	  (m,	  3H),	  2.13	  (s,	  3H),	  
2.02	  –	  1.99	  (m,	  6H),	  1.96	  (s,	  3H)	  ppm.	  
13C-­‐NMR	  (75	  MHz,	  CDCl3):	  δ=	  190.76,	  170.31,	  170.18,	  170.05,	  169.31,	  161.28,	  131.80,	  131.73,	  116.70,	  
98.46,	  71.27,	  70.63,	  68.38,	  66.79,	  61.37,	  20.67,	  20.62,	  20.60,	  20.53	  ppm.	  
Rf	  =	  0.4	  (cyclohexane	  :	  ethyl	  acetate	  /	  6:4	  /	  v:v)	  




6:	  [4-­‐(hydroxymethyl)phenyl]-­‐(2,3,4,6-­‐tetra-­‐O-­‐acetyl-­‐β-­‐D-­‐galactopyranoside)	  	  
To	   an	   ice-­‐cold	   solution	   of	   5	   (1.016g,	   2.25mmol,	   1.0eq.)	   in	   dry	   DCM	   (24mL)	   under	   an	   argon	  
atmosphere	  was	  added	  dropwise	  a	   solution	  of	   sodium	  borohydride	   (94mg,	  2.47mmol,	  1.1eq.),	  and	  
the	  reaction	  mixture	  was	  stirred	  at	  0°C	  for	  30min.	  The	  progress	  of	  the	  reaction	  can	  be	  monitored	  by	  
TLC	  (cyclohexane	  :	  ethyl	  acetate	  /	  6:4	  /	  v:v).	  After	  the	  completion	  of	  the	  reaction,	   it	  was	  quenched	  
with	  NH4Cl	   sat.	   (50mL),	   the	  organic	   layer	  was	   separated	   and	   the	   aqueous	   layer	  was	  washed	   three	  
times	   with	   DCM	   (3x50mL).	   The	   combined	   organic	   layers	   were	   dried	   with	   Na2SO4,	   filtered	   and	  
evaporated	  to	  dryness.	  The	  crude	  mixture	  was	  then	  purified	  via	  column	  chromatography	  on	  silicagel	  
(cyclohexane	  :	  ethyl	  acetate	  /	  6:4	  /	  v:v)	  to	  obtain	  6	  as	  white	  solid	  (815mg,	  1.80mmol,	  yield:	  80%).	  
NMR:	  1H-­‐NMR	  (300	  MHz,	  CDCl3):	  δ=	  7.31	  (d,	  J	  =	  8.6	  Hz,	  2H),	  6.99	  (d,	  J	  =	  8.6	  Hz,	  2H),	  5.53	  –	  5.43	  (m,	  
2H),	  5.11	  (dd,	  J	  =	  10.4,	  3.4	  Hz,	  1H),	  5.03	  (d,	  J	  =	  7.9	  Hz,	  1H),	  4.65	  (d,	  J	  =	  3.0	  Hz,	  2H),	  4.28	  –	  4.01	  (m,	  3H),	  
2.18	  (s,	  3H),	  2.07+2.06	  (2xs,	  6H),	  2.01	  (s,	  3H)	  ppm.	  
13C-­‐NMR	   (75	  MHz,	   CDCl3):	  δ=	   170.38,	   170.27,	   170.16,	   135.90,	   128.50,	   117.05,	   99.77,	   71.04,	   70.83,	  
68.63,	  66.86,	  64.81,	  61.36,	  20.68,	  20.61	  ppm.	  
Rf	  =	  0.30	  (cyclohexane	  :	  ethyl	  acetate	  /	  6:4	  /	  v:v)	  
Analysis	  data	  are	  consistent	  with	  those	  reported	  in	  the	  literature.[1]	  
	  
7:	  [4-­‐(4-­‐nitro-­‐phenoxycarbonyloxymethyl)phenyl]-­‐(2,3,4,6-­‐tetra-­‐O-­‐acetyl-­‐β-­‐D-­‐galactopyranoside)	  	  
To	   a	   solution	   of	   6	   (230mg,	   0.50mmol,	   1.0eq.)	   in	   dry	   DCM	   (10mL)	   was	   successively	   added	  
paranitrophenylchloroformate	  (231mg,	  1.11mmol,	  2.2eq.)	  and	  pyridine	  (105µL,	  1.27mmol,	  2.5eq.)	  at	  
RT.	  The	  reaction	  mixture	  was	  stirred	  at	  this	  temperature	  during	  5h.	  The	  progress	  of	  the	  reaction	  can	  
be	  monitored	  by	  TLC	  (cyclohexane	  :	  ethyl	  acetate	  /	  6:4	  /	  v:v).	  After	  the	  completion	  of	  the	  reaction,	  it	  
was	   quenched	   with	   water	   (20mL),	   the	   organic	   layer	   was	   separated	   and	   the	   aqueous	   layer	   was	  
washed	  once	  with	  DCM	  (20mL).	  The	  combined	  organic	   layers	  were	  dried	  with	  Na2SO4,	   filtered	  and	  
evaporated	  to	  dryness.	  The	  crude	  mixture	  was	  then	  purified	  via	  column	  chromatography	  on	  silicagel	  
(cyclohexane	  :	  ethyl	  acetate	  /	  65:35	  /	  v:v)	  to	  obtain	  7	  as	  white	  solid	  (303mg,	  0.49mmol,	  yield:	  98%).	  
-­‐S4-­‐	  
	  
NMR:	  1H-­‐NMR	  (300	  MHz,	  CDCl3):	  δ=	  8.27	  (d,	  J	  =	  9.0	  Hz,	  2H),	  7.38	  (t,	  J	  =	  8.4	  Hz,	  4H),	  7.03	  (d,	  J	  =	  8.4	  Hz,	  
2H),	  5.54	  –	  5.43	  (m,	  J	  =	  10.1,	  7.9	  Hz,	  2H),	  5.24	  (s,	  2H),	  5.12	  (dd,	  J	  =	  10.5,	  3.3	  Hz,	  1H),	  5.07	  (d,	  J	  =	  7.9	  
Hz,	  1H),	  4.28	  –	  4.04	  (m,	  3H),	  2.18	  (s,	  3H),	  2.06	  (s,	  6H),	  2.02	  (s,	  3H)	  ppm.	  
13C-­‐NMR	  (75	  MHz,	  CDCl3):	  δ=	  170.46,	  170.33,	  170.23,	  169.47,	  157.57,	  155.63,	  152.56,	  145.57,	  130.67,	  
129.23,	   125.44,	   121.88,	   117.22,	   99.56,	   71.26,	   70.90,	   70.62,	   68.73,	   66.96,	   61.46,	   20.85,	   20.78,	  
20.70	  ppm.	  
Rf	  =	  0.18	  (cyclohexane	  :	  ethyl	  acetate	  /	  7:3	  /	  v:v)	  





To	   a	   solution	   of	   2[2]	   (40mg,	   0.067mmol,	   1.0eq.)	   and	   DIPEA	   (30µL,	   0.168mmol,	   2.5eq.)	   in	   dry	   DCM	  
(5mL)	   under	   an	   argon	   atmosphere	   wad	   added	   7	   (42mg,	   0.067mmol,	   1.0eq.)	   at	   RT.	   The	   reaction	  
mixture	   was	   stirred	   at	   this	   temperature	   during	   10	   days.	   The	   progress	   of	   the	   reaction	   can	   be	  
monitored	  by	  TLC	  (petroleum	  ether	  :	  ethyl	  acetate	  /	  4:6	  /	  v:v).	  After	  the	  completion	  of	  the	  reaction,	  it	  
was	  diluted	  with	  DCM	  (10mL),	  and	  washed	  twice	  with	  water	  (2x20mL).	  The	  organic	   layer	  was	  dried	  
with	  Na2SO4,	   filtered	   and	   evaporated	   to	   dryness.	   The	   crude	  mixture	  was	   then	   purified	   via	   column	  
chromatography	   on	   silicagel	   (gradient	   of	   petroleum	   ether	   :	   ethyl	   acetate	   /	   6:4,	   5:5,	   4:6	   /	   v:v)	   to	  
obtain	  8	  as	  white	  solid	  (61mg,	  0.059mmol,	  yield:	  88%).	  
NMR:	  1H-­‐NMR	  (500	  MHz,	  CDCl3):	  δ=	  12.09	  –	  11.20	  (m,	  0.6H),	  8.51	  (s,	  0.5H),	  8.29	  (d,	  J	  =	  11.9	  Hz,	  0.5H),	  
8.21	  (m,	  0.3H),	  8.11	  –	  7.96	  (m,	  0.7H),	  7.90	  (d,	  J	  =	  9.1	  Hz,	  .05H),	  7.84	  –	  7.65	  (m,	  2H),	  7.50	  –	  7.34	  (m,	  
0.7H),	  7.33	  –	  7.11	  (m,	  1.5H),	  7.07	  (d,	  J	  =	  8.3	  Hz,	  0.5H),	  7.02	  –	  6.76	  (m,	  3H),	  5.48	  –	  5.36	  (m,	  2H),	  5.32	  
(d,	  J	  =	  8.1	  Hz,	  0.4H),	  5.28	  (s,	  2H),	  5.13	  –	  5.04	  (m,	  1H),	  5.03	  –	  4.92	  (m,	  1H),	  4.85	  –	  4.65	  (m,	  70.4),	  4.45	  –	  
4.26	  (m,	  1.5H),	  4.26	  –	  3.97	  (m,	  5H),	  3.88	  –	  3.08	  (m,	  2H),	  2.87	  –	  2.66	  (m,	  0.7H),	  2.16	  (s,	  3H),	  2.04	  (s,	  
6H),	  1.99	  (s,	  3H),	  1.88	  (M,	  0.4H),	  1.76	  –	  1.31	  (m,	  9H),	  1.01	  –	  0.79	  (m,	  7H)	  ppm.	  
13C-­‐NMR	   (125	   MHz,	   CDCl3):	   δ=	   174.32,	   173.38,	   173.31,	   173.07,	   170.43,	   170.34,	   170.22,	   169.47,	  
162.52,	   162.26,	   162.13,	   156.77,	   156.72,	   156.61,	   156.52,	   154.32,	   152.71,	   152.29,	   151.49,	   150.58,	  
150.34,	   148.81,	   148.39,	   148.13,	   147.97,	   147.69,	   135.62,	   135.57,	   135.49,	   135.36,	   133.44,	   133.27,	  
132.96,	   132.24,	   131.72,	   131.35,	   131.24,	   131.08,	   130.81,	   130.63,	   130.35,	   130.04,	   129.76,	   129.70,	  
129.61,	   129.23,	   128.51,	   127.93,	   126.14,	   126.04,	   126.00,	   125.75,	   125.38,	   124.74,	   124.17,	   123.35,	  
122.00,	   121.85,	   117.08,	   116.99,	   116.83,	   116.80,	   99.69,	   99.65,	   71.11,	   71.07,	   70.89,	   68.69,	   66.94,	  
66.70,	  65.96,	  61.46,	  61.41,	  53.58,	  53.54,	  53.27,	  52.83,	  50.32,	  40.99,	  40.81,	  40.72,	  40.47,	  40.41,	  39.57,	  
39.00,	  38.33,	  29.76,	  27.37,	  26.99,	  25.56,	  24.81,	  23.95,	  23.61,	  23.07,	  22.77,	  22.65,	  22.61,	  22.38,	  22.30,	  
20.91,	  20.81,	  20.74,	  20.66,	  19.25,	  19.15,	  17.58,	  17.37,	  14.74	  ppm.	  
-­‐S5-­‐	  
	  
HRMS:	  C49H56Cl2N5O16	  [M+H]+	  m/z	  found:	  1040.3045	  calc.	  1040.3094	  
Rf	  =	  0.45	  (petroleum	  ether	  :	  ethyl	  acetate	  /	  4:6	  /	  v:v)	  
	  
1:	   (S)-­‐4-­‐chloro-­‐2-­‐(6-­‐chloro-­‐4-­‐oxo-­‐3,4-­‐dihydroquinazolin-­‐2-­‐yl)phenyl	   2-­‐(((S)-­‐4-­‐methyl-­‐2-­‐((((4-­‐
(((2S,3R,4S,5R,6R)-­‐3,4,5-­‐trihydroxy-­‐6-­‐(hydroxymethyl)tetrahydro-­‐2H-­‐pyran-­‐2-­‐
yl)oxy)benzyl)oxy)carbonyl)amino)pentanamido)methyl)piperidine-­‐1-­‐carboxylate	  
To	   an	   ice-­‐cold	   solution	   of	   8	   (61mg,	   0.059mmol,	   1.0eq.)	   in	   dry	   MeOH	   (6mL)	   under	   an	   argon	  
atmosphere	  wad	  added	  sodium	  (14mg,	  0.59mmol,	  10eq.)	   in	  dry	  MeOH	  (4mL).	  The	  reaction	  mixture	  
was	  stirred	  at	  this	  temperature	  during	  1h30.	  The	  progress	  of	  the	  reaction	  can	  be	  monitored	  by	  MS	  
analysis	  (petroleum	  ether	  :	  ethyl	  acetate	  /	  4:6	  /	  v:v).	  After	  the	  completion	  of	  the	  reaction,	  Amberjet	  
1000H	  was	  added	   to	   the	  mixture	  until	   the	  pH	  gets	  neutral.	   It	  was	   then	   filtered	  and	  evaporated	   to	  
dryness.	   The	   crude	  mixture	  was	   then	  purified	   via	   column	   chromatography	  on	   silicagel	   (gradient	  of	  
DCM	  :	  MeOH	  /	  94:6,	  93:7	  /	  v:v)	  to	  obtain	  1	  as	  white	  solid	  (40mg,	  0.046mmol,	  yield:	  79%).	  
NMR:	  1H-­‐NMR	  (500	  MHz,	  CD3OD):	  δ=	  8.20	  (s,	  1H),	  7.87	  –	  7.78	  (m,	  J	  =	  8.7	  Hz,	  2H),	  7.78	  –	  7.69	  (m,	  J	  =	  
8.0	  Hz,	  1H),	  7.61	  –	  7.44	  (m,	  J	  =	  33.8	  Hz,	  1H),	  7.42	  –	  7.17	  (m,	  3H),	  7.07	  (d,	  J	  =	  8.3	  Hz,	  2H),	  4.98	  (s,	  2H),	  
4.80	  –	  4.70	  (m,	  0.5H),	  4.62	  –	  4.49	  (m,	  0.5H),	  4.28	  –	  3.99	  (m,	  J	  =	  44.4	  Hz,	  2H),	  3.92	  (s,	  1H),	  3.86	  –	  3.71	  
(m,	  4H),	  3.71	  –	  3.54	  (m,	  J	  =	  47.0	  Hz,	  2.5H),	  3.54	  –	  3.42	  (m,	  J	  =	  10.6	  Hz,	  0.5H),	  3.42	  –	  3.30	  (m,	  J	  =	  19.4	  
Hz,	  2.5H),	  3.26	  –	  2.86	  (m,	  2H),	  1.74	  –	  1.27	  (m,	  9H),	  0.89	  (s,	  6H)	  ppm.	  
13C-­‐NMR	   (125	   MHz,	   CD3OD):	   δ=	   175.74,	   175.51,	   163.12,	   159.02,	   158.38,	   154.43,	   154.24,	   154.08,	  
152.57,	   150.81,	   149.19,	   148.58,	   138.17,	   136.24,	   134.03,	   132.87,	   132.06,	   131.87,	   131.77,	   130.98,	  
130.81,	  130.53,	  130.42,	  130.12,	  129.84,	  126.47,	  125.05,	  123.42,	  117.66,	  102.85,	  76.91,	  74.81,	  72.25,	  
70.17,	  67.35,	  62.37,	  55.08,	  53.47,	  53.00,	  52.52,	  52.32,	  42.15,	  42.00,	  41.59,	  41.39,	  41.03,	  39.50,	  39.22,	  
39.07,	  33.05,	  30.75,	  28.44,	  27.32,	  27.03,	  26.88,	  26.35,	  26.07,	  25.86,	  23.89,	  23.45,	  21.88,	  21.74,	  19.83	  
ppm.	  
HRMS:	  C41H48Cl2N5O12	  [M+H]+	  m/z	  found:	  872.2666	  calc.	  872.2671	  




2.1 In	  vitro	  analyses	  
2.1.1 Both	  LAP	  and	  β-­‐Gal	  activities	  are	  required	  to	  get	  fluorescence	  from	  probe	  1	  
To	  a	  solution	  of	  probe	  1	   in	  PBS	  (Dulbecco’s	  Phosphate	  Buffer	  Saline,	  Invitrogen	  Corp.)	  preheated	  to	  
37°C	   in	   a	   96-­‐well	   black	   plate	   (Microfluor®,	   Thermo	   Scientific)	   was	   added	   either	   a	   mixture	   of	   LAP	  
(Leucine	  Aminopeptidase,	  microsomal	   from	  porcine	  kidney,	  Type	   IV-­‐S,	  Sigma-­‐Aldrich)	  and	  β-­‐Gal	   (β-­‐
Galactosidase	   from	  Escherichia	   coli,	  Grade	  VIII,	   Sigma-­‐Aldrich)	   in	  PBS	  or	   LAP	  only,	  or	  β-­‐Gal	  only,	  or	  
none	  of	  these	  enzymes.	  
Final	  concentration	  of	  probe	  1:	  100µM	  
Final	  concentration	  of	  LAP:	  0.007U	  
Final	  concentration	  of	  β-­‐Gal:	  1U	  
Final	  concentration	  of	  DMSO:	  0.1%	  
The	  plate	  was	  then	  incubated	  at	  37	  °C	  and	  fluorescence	  was	  recorded	  over	  the	  course	  of	  time	  by	  a	  
fluorescence	  plate	  reader	   (EnSpire,	  Perkin	  Elmer	   -­‐	  λex	  =	  360	  nm,	  λem=	  530	  nm).	  The	  resulting	  curves	  
(Figure	  2.A	  and	  (Figure	  2.B)	  are	  the	  mean	  of	  triplicates.	  
2.1.2 Influence	  of	  probe	  concentration	  on	  fluorescence	  signal	  
The	  same	  protocol	  was	  used	  as	  in	  2.2.1	  but	  with	  a	  range	  of	  concentrations	  of	  probe	  1	  incubated	  with	  
the	  mixture	  of	  LAP	  and	  β-­‐Gal.	  
Final	  concentration	  of	  probe	  1:	  range	  from	  1µM	  to	  10µM	  
Final	  concentration	  of	  LAP:	  0.007U	  
Final	  concentration	  of	  β-­‐Gal:	  1U	  
Final	  concentration	  of	  DMSO:	  from	  0.001%	  to	  0.01%	  
The	  plate	  was	  then	  incubated	  at	  37	  °C	  and	  fluorescence	  was	  recorded	  over	  the	  course	  of	  time	  by	  a	  
fluorescence	  plate	  reader	   (EnSpire,	  Perkin	  Elmer	   -­‐	  λex	  =	  360	  nm,	  λem=	  530	  nm).	  The	  resulting	  curves	  
(Figure	  2.C)	  are	  the	  mean	  of	  triplicates.	  
2.2 In	  cellulo	  assay	  
2.2.1 Cell	  culture	  
HeLa	  and	  C17-­‐2	  (stably	  transfected	  with	  LacZ	  gene)	  cells	  were	  cultured	  in	  Dulbecco’s	  modiﬁed	  Eagle’s	  
medium	   (DMEM,	   Invitrogen	   Corp.)	   supplemented	   with	   10	  %	   (v/v)	   fetal	   bovine	   serum	   (Invitrogen	  
Corp.),	  50	  U.mL-­‐1	  penicillin,	  and	  50	  µg.mL-­‐1	  streptomycin	  (Invitrogen	  Corp.)	  in	  a	  humidified	  incubator	  
containing	  5	  %	  CO2	  in	  air	  at	  37°C.	  
2.2.2 Incubation	  of	  cells	  with	  probe	  1	  
8.104	  HeLa	  cells	  or	  C17-­‐2	  cells	  were	  seeded	  in	  500	  µL	  of	  supplemented	  DMEM	  in	  a	  clear	  24-­‐well	  plate	  
(Corning	  Costar).	   After	   24	  h	  of	   incubation,	   the	  medium	  was	   removed,	   cells	  were	  washed	  with	   PBS	  
-­‐S7-­‐	  
	  
and	  the	  medium	  was	  replaced	  by	  450µL	  of	  supplemented	  DMEM.	  50µL	  of	  a	  stock	  solution	  of	  probe	  1	  
at	   500	  µM	   (in	   PBS,	   containing	   1	  %	   DMSO)	   to	   have	   a	   final	   concentration	   of	   50	  µM	   in	   500	  µL	   final	  
volume.	  Cells	  were	  then	  incubated	  for	  4	  h	  before	  images	  were	  taken	  (Figure	  3).	  
Fluorescence	  images	  were	  captured	  using	  a	  Zeiss	  AxioObserver	  Z1	  instrument	  with	  EC	  Plan	  Neofluar	  
10x	  objective	  lens.	  The	  light	  source	  was	  metal	  halide	  fluorescence	  HPX	  100.	  For	  fluorescence	  imaging	  
the	   Zeiss	   filter	   set	   21HE	   was	   used	   with	   λex=	  325	  –	  355	  nm	   and	   λem=	  470	  –	  555	  nm.	   Images	   were	  
acquired	  with	  an	  AxioCam	  MRm3	  S/N	  5762.	  Exposure	  time	  was	  200	  ms	  for	  both	  dyes	  and	  20	  ms	  for	  
brightfield	  images.	  
2.2.3 Inhibition	  of	  LAP	  activity	  in	  C17-­‐2	  cells	  
The	   same	   procedure	  was	   used	   as	   described	   in	   2.2.2	   but	   C17-­‐2	   cells	   were	   incubated	  with	   5µM	   of	  




3 NMR	  spectra	  
	  
As	  a	  preamble,	  it	  should	  be	  noted	  that	  NMR	  spectra	  of	  compound	  1	  and	  8	  are	  very	  complex	  because	  
of	  the	  presence	  of	  diastereoisomers	  (racemic	  aminomethylpiperidine	  spacer),	  conformers	  (piperidine	  
chair)	  and	  rotamers	  (carbamate	  units).	  To	  confirm	  the	  structures,	  2D	  experiments	  (COSY,	  HSQC,	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